Staghorn Calculus with Declining Renal Function: Sequencing the Intervention
A 52-year-old woman with recurrent struvite stones presents with a 4.5 cm left staghorn calculus, a creatinine of 1.6 mg/dL (baseline 0.9), and a serum potassium of 5.6 mEq/L. She has had two prior episodes of pyelonephritis in the last year and a history of a ureteropelvic junction obstruction treated with pyeloplasty 8 years ago. Non-contrast CT shows moderate left hydronephrosis and the stone filling the renal pelvis and lower pole calyces. She is afebrile with normal white count. Urine culture grows Proteus mirabilis. She is on no anticoagulation.
1. What is the immediate priority, and how does the positive Proteus culture and hydronephrosis change your sequencing?
Read the worked answer
The immediate priority is drainage and infection control before definitive stone surgery. Reasoning:
- Obstructed, infected system = risk of urosepsis. Even though she is currently afebrile, a positive Proteus culture with hydronephrosis and declining renal function means the kidney is at risk. Placement of a ureteral stent or percutaneous nephrostomy decompresses the system.
- Percutaneous nephrostomy is often preferred here because it provides drainage and establishes a tract that can later be used for percutaneous nephrolithotomy (PCNL), which is the treatment of choice for a 4.5 cm staghorn.
- Culture-directed antibiotics (Proteus) should be started/optimized before any instrumentation.
- Hyperkalemia (5.6) and rising creatinine require medical management and nephrology input; the obstructed kidney contributes to the decline.
Definitive stone clearance is deferred until the infection is controlled and the patient is metabolically optimized. Do not proceed directly to PCNL in an actively infected, obstructed system.
2. After drainage and antibiotic therapy, what is the definitive stone plan, and how do you counsel her about number of procedures and residual fragments?
Read the worked answer
Definitive plan: percutaneous nephrolithotomy (PCNL), ideally through the existing nephrostomy tract, for the 4.5 cm staghorn. Reasoning:
- Size and configuration: Staghorn >2 cm and complex lower-pole involvement make PCNL first-line; ureteroscopy alone would require multiple sessions with lower clearance rates.
- Anatomy: Prior pyeloplasty means altered UPJ anatomy; PCNL avoids relying on ureteral access and allows direct access to the collecting system.
- Infection source: Struvite/Proteus stones require complete removal to eradicate the nidus; residual fragments perpetuate infection and regrowth.
Counseling points:
- Staged procedures are common for staghorn; plan for possible second-look nephroscopy.
- Residual fragments >4 mm are associated with recurrence and should be pursued with secondary procedures.
- Metabolic/structural workup (stone analysis, 24-hour urine, anatomic evaluation) and consideration of urease-producing organism eradication.
- Recurrence risk is high with struvite; discuss surveillance imaging and the role of complete clearance in preventing regrowth.